Developing vaccines for infectious diseases including SARS-CoV-2

Task V25: PROCESS DEVELOPMENT FOR VACCINE CANDIDATES INCLUDING SARS-COV-2

NIH-funded research Advanced Bioscience Laboratories, INC. · NIH-10168825

This study is all about creating new vaccines to help protect people from infectious diseases like COVID-19, and it's aimed at making sure these vaccines are safe and effective for everyone.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionAdvanced Bioscience Laboratories, INC. NIH-funded
Lab location1 site (Kensington, United States)
Project IDNIH-10168825 on NIH RePORTER

What this research studies

This research focuses on the development and manufacturing of vaccines and biologics to combat infectious diseases, including SARS-CoV-2. It involves planning and optimizing vaccine products, ensuring compliance with regulatory standards, and conducting clinical studies. Patients may benefit from new vaccines that are designed to protect against emerging infectious threats and bioterrorism. The research includes comprehensive support for vaccine formulation and delivery systems.

Who could benefit from this research

Good fit: Ideal candidates for participation or benefit from this research include individuals at risk for infectious diseases, particularly those vulnerable to SARS-CoV-2 and other emerging pathogens.

Not a fit: Patients who are not at risk for infectious diseases or those who have already been vaccinated against SARS-CoV-2 may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of effective vaccines that protect patients from serious infectious diseases.

How similar studies have performed: Previous research has shown success in developing vaccines for infectious diseases using similar methodologies, indicating a promising approach.

Where this research is happening

Kensington, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Communicable DiseasesInfectious Disease PathwayInfectious DiseasesInfectious Disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.